<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
    <title>BIO Asia International</title>
    <description>
      <![CDATA[]]>
    </description>
    <link>https://www.bioworld.com/rss</link>
    <language>en-us</language>
    <item>
      <title>Real-world data illuminates Rakuten's Alluminox solid tumor platform</title>
      <description>
        <![CDATA[Rakuten Medical Inc. is advancing a pipeline of solid tumor therapeutics built on its Alluminox platform worldwide, having gained conditional early approval of ASP-1929, an Alluminox-derived photoimmunotherapy, in Japan in 2020.]]>
      </description>
      <guid>http://www.bioworld.com/articles/724549</guid>
      <pubDate>Fri, 26 Sep 2025 10:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/724549-real-world-data-illuminates-rakutens-alluminox-solid-tumor-platform</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Therapeutic-topics/ENT/Head-and-neck-anatomy.webp?t=1735588294" type="image/jpeg" medium="image" fileSize="168445">
        <media:title type="plain">Head and neck anatomy</media:title>
      </media:content>
    </item>
    <item>
      <title>India could be instrumental in lowering price of CAR T-cell therapy</title>
      <description>
        <![CDATA[HYDERABAD, India – India could play a key role in driving down the exorbitant cost of emerging cell and gene therapies, with a combination of comparatively cheap labor and efficient manufacturing, international experts said during the annual BioAsia conference.]]>
      </description>
      <guid>http://www.bioworld.com/articles/433298</guid>
      <pubDate>Tue, 25 Feb 2020 14:21:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/433298-india-could-be-instrumental-in-lowering-price-of-car-t-cell-therapy</link>
    </item>
    <item>
      <title>India ramps up efforts to move up biotech value chain</title>
      <description>
        <![CDATA[HYDERABAD, India – Multinationals and domestic companies are stepping up research in India, including working to leverage the country’s digital and entrepreneurial capabilities, to boost India’s capabilities and market share in more innovative biologic drugs.]]>
      </description>
      <guid>http://www.bioworld.com/articles/433297</guid>
      <pubDate>Tue, 25 Feb 2020 14:19:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/433297-india-ramps-up-efforts-to-move-up-biotech-value-chain</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Geographic-regions/India/India-pill-bottle-drugs.webp?t=1588688457" type="image/png" medium="image" fileSize="125387">
        <media:title type="plain">Pill bottle with flag of India</media:title>
      </media:content>
    </item>
    <item>
      <title>Digital strategies key for Indian pharma</title>
      <description>
        <![CDATA[HYDERABAD, India – To continue expanding their footprint and capabilities beyond simple generics to biosimilars and new chemical entities, Indian pharmaceutical companies will have to improve their quality controls, compliance capabilities and, just as importantly, adopt more effective digital strategies.]]>
      </description>
      <guid>http://www.bioworld.com/articles/433220</guid>
      <pubDate>Fri, 21 Feb 2020 12:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/433220-digital-strategies-key-for-indian-pharma</link>
    </item>
    <item>
      <title>India ramps up efforts to move up biotech value chain</title>
      <description>
        <![CDATA[HYDERABAD, India – Multinationals and domestic companies are stepping up research in India, including working to leverage the country’s digital and entrepreneurial capabilities, to boost India’s capabilities and market share in more innovative biologic drugs.]]>
      </description>
      <guid>http://www.bioworld.com/articles/433186</guid>
      <pubDate>Thu, 20 Feb 2020 12:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/433186-india-ramps-up-efforts-to-move-up-biotech-value-chain</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Geographic-regions/India/India-pill-bottle-drugs.webp?t=1588688457" type="image/png" medium="image" fileSize="125387">
        <media:title type="plain">Pill bottle with flag of India</media:title>
      </media:content>
    </item>
    <item>
      <title>India could be instrumental in lowering price of CAR T-cell therapy</title>
      <description>
        <![CDATA[HYDERABAD, India – India could play a key role in driving down the exorbitant cost of emerging cell and gene therapies, with a combination of comparatively cheap labor and efficient manufacturing, international experts said during the annual BioAsia conference.]]>
      </description>
      <guid>http://www.bioworld.com/articles/433157</guid>
      <pubDate>Wed, 19 Feb 2020 12:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/433157-india-could-be-instrumental-in-lowering-price-of-car-t-cell-therapy</link>
    </item>
  </channel>
</rss>
